Imida 0.1 mg belongs to the generic category of Imidafenacin. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Imida 0.1 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Imidafenacin and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

*Up to 10% Discount
(Depends on pharmacy)
/ Piece
Imida 0.1 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Imida 0.1 mg is provided below to help users gain a clear understanding of this medicine.
Imida 0.1 mg (Imidafenacin) tablet is indicated for the treatment of overactive bladder with symptoms of urinary urgency, urinary frequency, and urge urinary incontinence.
Imida 0.1 mg (Imidafenacin) is an anti-muscarinic agent. Imidafenacin exerts its effects by selectively blocking muscarinic receptors, specifically the M3 subtype, which are predominantly found in the detrusor muscle of the bladder. Muscarinic receptors are a type of acetylcholine receptor that play a critical role in the contraction of smooth muscles, including those in the bladder. When acetylcholine binds to these receptors, it triggers a cascade of events that result in muscle contraction, facilitating the process of urination.
The usual oral dose of Imida 0.1 mg (Imidafenacin) for adults is 0.1 mg twice daily, after the meal. If necessary, the dosage may be increased up to 0.2 mg twice daily (0.4 mg/day) or as directed by the physician. The safety and effectiveness of Imidafenacin in paediatric patients have not been established.
CYP3A4 inhibiting agents such as Itraconazole, Ketoconazole, Erythromycin, and Clarithromycin have the possibility of increased blood serum Imida 0.1 mg (Imidafenacin) concentration, which in turn increases the risk of overdose. Anticholinergic effects of Imida may escalate in case of concomitant administration of anti-histamins, tricyclic anti-depressants, phenothiazines and monoamino oxidase inhibitors may increase the risk of side effects.
Clinically significant adverse reactions to Imida 0.1 mg (Imidafenacin) are acute glaucoma, urinary retention, and hepatic dysfunction. The most common adverse effects observed with Imida are dry mouth and constipation.
Careful administration should be needed for the following patients- Patients with dysuria, arrhythmia, hepatic dysfunction, renal dysfunction, dementia or cognitive dysfunction, cerebrovascular disorder, ulcerative colitis and hyperthyroidism.
Product safety is not established during pregnancy and lactation.
BPH/ Urinary retention/ Urinary incontinence
Store below 25°C, away from light and in a dry place. Keep all medicines out of the reach of children. Pack Image: Imida 0.1 mg Tablet Thanks for using MedEx! How would you rate your experience so far?
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

N.B.: All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines.
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023